PT-141 Downstream Effects: Research Applications Comparison
Vascular function studies eNOS activation → NO release → cGMP elevation → smooth muscle relaxation Systemic vasodilation, reduced arterial pressure, increased tissue perfusion 45–60 minutes 6–8 hours Most reliable downstream effect with consistent dose-respons
This comparison does not assign a generated winner or score.
- Vascular function studies
- eNOS activation → NO release → cGMP elevation → smooth muscle relaxation
- Systemic vasodilation, reduced arterial pressure, increased tissue perfusion
- 45–60 minutes
- 6–8 hours
- Most reliable downstream effect with consistent dose-response relationship across models
- Neurotransmitter modulation research
- MC4R in PVN → oxytocin release → D2 receptor sensitization
- Indirect dopamine potentiation, CREB phosphorylation in limbic structures
- 30–45 minutes
- 4–6 hours
- Highly variable between subjects due to baseline dopaminergic tone differences
- Melanocortin receptor mapping
- MC3R/MC4R activation → cAMP elevation → PKA phosphorylation cascade
- CREB activation, gene transcription changes, receptor desensitization over repeated dosing
- 15–30 minutes (biochemical), 60–90 minutes (behavioral)
- 8–12 hours (signaling), 2–4 hours (subjective)
- Gold standard for studying melanocortin system function without confounding MC1R/MC5R activity
- Metabolic signaling studies
- MC3R in adipose tissue → HSL activation → lipolysis
- Increased free fatty acid mobilization, temporary insulin sensitivity improvement
- 60–90 minutes
- Limited clinical relevance. Effect magnitude insufficient for therapeutic metabolic intervention